Greentown Labs has announced a new accelerator that's dual located in its Houston and Boston-area locations. Photo via GreentownLabs.com

A climatetech incubator with locations in Houston and Somerville, Massachusetts, has announced an accelerator program with a corporate partner.

Greentown Labs and Saint-Gobain, a multinational manufacturer and distributor of high-performance materials, have opened applications for Greentown Go Build 2023. The program intends to support and accelerate startup-corporate partnerships to advance climatetech, specifically focused on circularity and decarbonizing the built environment per a news release from Greentown.

It's the third Greentown Go Build program the incubator has hosted. Applications, which are open online, are due by August 31.

“The Greentown Go Build program is an opportunity for innovative startups to share how they are disrupting the construction market with innovative and sustainable solutions that address the need for circularity and sustainability and that align with our mission of making the world a better home,” says Minas Apelian, vice president of external and internal venturing at Saint-Gobain. “Through this program, we are eager to identify companies dedicated to reducing our reliance on raw materials and associated supply chain risk to ensure circular solutions result in profitable, sustainable growth for business and sustainable construction solutions for our industries.”

For the six months of the program, the startups selected for the program will have access to mentorship, networking opportunities, and workshops. Program benefits for the participating startups, according to Greentown, include:

  • Access to a structured platform to engage leadership from Saint-Gobain and explore potential partnerships
  • A $25,000 stipend per startup
  • Access to Greentown's community of mentors, partners, and community of climatetech startup experts
  • Access to Saint-Gobain network
  • Desk space and membership within Greentown for the duration of the program

“We are thrilled to be building on our successful track record of Greentown Go programs with Saint-Gobain and look forward to driving decarbonization of the sector through startup-corporate partnerships,” says Kevin T. Taylor, CFO and interim CEO at Greentown Labs. “Saint-Gobain has been an exemplary partner for our Greentown Go programs and for Greentown more broadly—working collaboratively with our startups and deploying many of their technologies. We are eager to meet the world-class building tech startups that apply for the program.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.